Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
[en] AIMS: To critically review the available transcatheter aortic valve implantation techniques and their results, as well as propose recommendations for their use and development. METHODS AND RESULTS: A committee of experts including European Association of Cardio-Thoracic Surgery and European Society of Cardiology representatives met to reach a consensus based on the analysis of the available data obtained with transcatheter aortic valve implantation and their own experience. The evidence suggests that this technique is feasible and provides haemodynamic and clinical improvement for up to 2 years in patients with severe symptomatic aortic stenosis at high risk or with contraindications for surgery. Questions remain mainly concerning safety and long-term durability, which have to be assessed. Surgeons and cardiologists working as a team should select candidates, perform the procedure, and assess the results. Today, the use of this technique should be restricted to high-risk patients or those with contraindications for surgery. However, this may be extended to lower risk patients if the initial promise holds to be true after careful evaluation. CONCLUSION: Transcatheter aortic valve implantation is a promising technique, which may offer an alternative to conventional surgery for high-risk patients with aortic stenosis. Today, careful evaluation is needed to avoid the risk of uncontrolled diffusion.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Vahanian, Alec
Alfieri, Ottavio R
Al-Attar, Nawwar
Antunes, Manuel J
Bax, Jeroen
Cormier, Bertrand
Cribier, Alain
De Jaegere, Peter
Fournial, Gerard
Kappetein, Arie Pieter
Kovac, Jan
Ludgate, Susanne
Maisano, Francesco
Moat, Neil
Mohr, Friedrich-Wilhelm
Nataf, Patrick
Pierard, Luc ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., and Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 368 (2006) 1005-1011
Iung B., Baron G., Butchart E.G., Delahaye F., Gohlke-Bärwolf C., Levang O.W., Tornos P., Vanoverschelde J.L., Vermeer F., Boersma E., Ravaud P., and Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular disease. Eur Heart J 24 (2003) 1231-1243
American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Society of Cardiovascular Anesthe-siologists, Society for Cardiovascular Angiography Interventions, Society of Thoracic Surgeons; Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-e231.
Vahanian A., Baumgartner H., Bax J., Butchart E., Dion R., Filippatos G., Flachskampf F., Hall R., Iung B., Kasprzak J., Nataf P., Tornos P., Torracca L., and Wenink A. Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28 (2007) 230-268
Kolh P., Kerzmann A., Honore C., Comte L., and Limet R. Aortic valve surgery in octogenarians: predictive factors for operative and long term results. Eur J Cardiothorac Surg 31 (2007) 600-606
Melby S.J., Zierer A, Kaiser Y.P., Guthrie T.J., Keune J.D., Schuessler R.B., Pasque M.K., Lawton J.S., Moazami N., Moon M.J., and Damiano Jr. R.J. Aortic valve replacement in octogenarians. Risk factors for early and late mortality. Ann Thorac Surg 83 (2007) 1651-1657
Iung B., Cachier A., Baron G., Messika-Zeitoun D., Delahaye F., Tornos P., Gohlke-Bärwolf C., Boersma E., Ravaud P., and Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J 26 (2005) 2714-2720
Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., and Leon M.B. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (2002) 3006-3008
Vassiliades TA Jr, Block PC, Cohn LH, Adams DH, Borer JS, Feldman T, Holmes DR, Laskey WK, Lytle BW, Mack MJ, Williams DO; Society of Thoracic Surgeons (STS), American Association for Thoracic Surgery (AATS), Society for Cardiovascular Angiography Interventions (SCAI), American College of Cardiology Foundation (ACCF), American Heart Association (AHA). The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI). Ann Thorac Surg 2005;79:1812-8.
Rosengart TK, Feldman T, Borger MA, Vassiliades TA Jr, Gillinov AM, Hoercher KJ, Vahanian A, Bonow RO, O'Neill W. Percutaneous and minimally invasive valve procedures. A scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2008;117:1750-67.
De Jaegere P., Van Dijk L.C., Laborde J.C., Sianos G., Orellana Ramos F.J., Lighart J., Kappetein A.P., van der Ent M., and Serruys P.W. True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access. Prostar® XL and the TandemHeart®. EuroIntervention 2 (2007) 500-505
Cribier A., Eltchaninoff H., Tron C., Bauer F., Agatiello C., Sebagh L., Bash A., Nusimovici D., Litzler P.Y., Bessou J.P., and Leon M.B. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 43 (2004) 698-703
Cribier A., Eltchaninoff H., Tron C., Bauer F., Agatiello C., Nercolini D., Tapiero S., Litzler P.Y., Bessou J.P., and Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 47 (2006) 1214-1223
Grube E., Laborde J.C., Gerckens U., Felderhoff T., Sauren B., Buellesfeld L., Mueller R., Menichelli M., Schmidt T., Zickmann B., Iversen S., and Stone G.W. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114 (2006) 1616-1624
Webb J.G., Chandavimol M., Thompson C.R., Ricci D.R., Carere R.G., Munt B.I., Buller C.E., Pasupati S., and Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113 (2006) 842-850
Webb J.G., Pasupati S., Humphries K., Thompson C., Altwegg L., Moss R., Sinhal A., Carere R.G., Munt B., Ricci D., Ye J., Cheung A., and Lichtenstein S.V. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116 (2007) 755-763
Grube E., Schuler G., Buellesfeld L., Gerckens U., Linke A., Wenaweser P., Sauren B., Mohr F.W., Walther T., Zickmann B., Iversen S., Felderhoff T., Cartier R., and Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50 (2007) 69-76
Lichtenstein S.V., Cheung A., Ye J., Thompson C.R., Carere R.G., Pasupati S., and Webb J.G. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114 (2006) 591-596
Walther T., Simon P., Dewey T., Wimmer-Greinecker G., Falk V., Kasimir M.T., Doss M., Borger M.A., Schuler G., Glogar D., Fehske W., Wolner E., Mohr F.W., and Mack M. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 116 Suppl. (2007) I240-I245
Ye J., Cheung A., Lichtenstein S.V., Pasupati S., Carere R.G., Thompson C.R., Sinhal A., and Webb J.G. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg 31 (2007) 16-21
Edwards F.H., Peterson E.D., Coombs L.P., DeLong E.R., Jamieson W.R., Shroyer A.L.W., and Grover F.L. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37 (2001) 885-892
Roques F., Nashef S.A., Michel P., and EuroSCORE study group. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis 10 (2001) 572-577
STS National Database. STS US Cardiac Surgery Database: 1997 Aortic Valve Replacement Patients: Preoperative Risk Variables. Chicago: Society of Thoracic Surgeons; 2000. http://www.ctsnet.org/doc/3031. (10 May 2006).
Ambler G., Omar R.Z., Royston P., Kinsman R., Keogh B.E., and Taylor K.M. Generic, simple risk stratification model for heart valve surgery. Circulation 112 (2005) 224-231
Dewey T.M., Brown D., Ryan W.H., Herbert M.A., Prince S.L., and Mack M.J. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 135 (2008) 180-187
Schelbert E.B., Vaughan-Sarrazin M.S., Welke K.F., and Rosenthal G.E. Hospital volume and selection of valve type in older patients undergoing aortic valve replacement surgery in the United States. Circulation 111 (2005) 2178-2182
Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006;295:801-8 [Erratum in JAMA 2006;295:1900].
Tops LF, Wood DA, Delgado V, Schuijf JD, Mayo JR, Pasupati S, Lamers FPL, van der Wall EE, Schalij MJ, Webb JG, Bax JJ. Noninvasive evaluation of the aortic root with multislice computed tomography: implications for transcatheter aortic valve replacement. J Am Coll Cardiol Imaging, in press.
Moss R.R., Ivens E., Pasupati S., Humphries K., Thompson C.R., Munt B., Sinhal A., and Webb J.G. Role of echocardiography in percutaneous aortic valve implantation. J Am Coll Cardiol Imaging 1 (2008) 15-24
Zegdi R., Ciobotaru V., Noghin M., Sleilaty G., Lafont A., Latremouille C., Deloche A., and Fabiani J.N. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results form a human anatomic study in adults. J Am Coll Cardiol 51 (2008) 579-584
Ludgate S. A user's guide to overcoming roadblocks: the European approval process. EuroIntervention 1 Suppl. A (2006) A79-A80
Zuckerman B.D. The FDA role in the development of percutaneous heart valve technology. EuroIntervention 1 Suppl. A (2006) A75-A78
Grunkemeier G.L., Jin R., and Starr A. Prosthetic heart valves: objective performance criteria versus randomised clinical trial. Ann Thorac Surg 82 (2006) 776-780
Descoutures F, Himbert D, Lepage L, Iung B, Detaint D, Tchetche D, Brochet E, Castier Y, Depoix JP, Nataf P, Vahanian A. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J 2008; epub ahead of print 6 March.